logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Hybridon, Inc.


USPTO Granted Patents = 98

% Expired Patents = 1.0


Trademarks = 3

Forward Citations = 3,625

Loading Chart...
Loading Chart...

72 inventors (with patents filed for the assignee):

goldMedal Sudhir Agrawal (53 out of 153 patents)

silverMedal Radhakrishnan P Iyer (13 out of 38 patents)

bronzeMedal Dong Yu (11 out of 66 patents)

4.  John Goodchild (11 out of 11 patents)

5.  Gregory S Robinson (11 out of 12 patents)

6.  Ivan Habus (11 out of 11 patents)

7.  Jin-Yan Tang (8 out of 17 patents)

8.  Ekambar R Kandimalla (6 out of 78 patents)

9.  Qiuyan Zhao (6 out of 15 patents)

10.  Ruiwen Zhang (6 out of 6 patents)

11.  Aharon S Cohen (6 out of 15 patents)

12.  Thomas E Leonard (6 out of 6 patents)

13.  Eric Von Hofe (5 out of 7 patents)

14.  Theresa Devlin (5 out of 5 patents)

15.  Bruce L Frank (4 out of 4 patents)


Core Competencies:
Oligonucleotides
Hepatitis B
Tumor Growth
Gene Expression
Antisense
VEGF
CpG
Drug Resistance
Metastatic Cancer
Synthesis
Immunostimulation
Nucleic Acid

98 patents:

1. 6984729 - Oligonucleotides specific for hepatitis B virus (2006-01-10),
2. 6946447 - MDM2-specific antisense oligonucleotides (2005-09-20),
3. 6936593 - Method of down-regulating gene expression (2005-08-30),
4. 6815429 - Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides (2004-11-09),
5. 6667293 - Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response (2003-12-23),
6. 6649596 - Modified VEGF Oligonucleotides for Inhibition of tumor growth (2003-11-18),
7. 6645943 - Method of down-regulating gene expression (2003-11-11),
8. 6624293 - Modified protein kinase A-specific oligonucleotides and methods of their use (2003-09-23),
9. 6608035 - Method of down-regulating gene expression (2003-08-19),
10. 6605708 - Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom (2003-08-12),
11. 6531589 - Base protecting groups and synthons for oligonucleotide synthesis (2003-03-11),
12. 6509459 - Base protecting groups and rapid process for oligonucleotide synthesis (2003-01-21),
13. 6509149 - HPV-specific oligonucleotides (2003-01-21),
14. 6489464 - Branched oligonucleotides as pathogen-inhibitory agents (2002-12-03),
15. 6489304 - Hyperstructure-forming carriers (2002-12-03),
Hybridon, Inc. is a leading biotechnology company specialized in the development of innovative RNA-based therapies. With our cutting-edge technology and expertise, we are dedicated to advancing the field of drug discovery and improving patient outcomes. Visit our website to learn more about our groundbreaking research and the latest advancements in RNA therapeutics.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Hybridon, Inc.
98 Patents

#31 in Cambridge, MA

#214 in Massachusetts

#3,847 in US

#7,903 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Hybridon, Inc.

Forward Citations = 3,625

72 inventors:

goldMedal Sudhir Agrawal (53 out of 153 patents)

silverMedal Radhakrishnan P Iyer (13 out of 38 patents)

bronzeMedal Dong Yu (11 out of 66 patents)

4.  John Goodchild (11 out of 11 patents)

5.  Gregory S Robinson (11 out of 12 patents)

Please report any incorrect information to [email protected]
Loading…